Wolverine Stack
BPC-157 / TB-500
About
Wolverine Stack is a peptide blend that combines two compounds studied individually for tissue repair. BPC-157 (Body Protection Compound 157) is a synthetic fragment derived from a peptide described in gastric juice and is associated in research with angiogenesis, collagen synthesis, and cell growth across tissue types. TB-500 is a synthetic peptide related to thymosin beta-4, a protein involved in tissue repair and regeneration. The combination is discussed in both injectable and capsule-oriented research contexts, and blend-specific human evidence remains limited.
Research Applications
- Regenerative and tissue repair
- Soft-tissue and injury recovery
- Combination therapy pairing BPC-157 and TB-500
Mechanism of Action
The blend pairs BPC-157's reported angiogenic, collagen-promoting, and cytoprotective activity with TB-500's role in actin regulation and tissue repair, with the combination intended to act across complementary repair pathways. These remain research observations rather than established clinical claims.
Molecular Info
- Class
- Peptide blend
- Components
- BPC-157 (Body Protection Compound 157) and TB-500 (thymosin beta-4 fragment)
- Formulations
- Injectable and oral capsule
- Primary research areas
- Tissue repair, wound healing, and recovery
Dosing Guidance
- Range
- Research discussions state there is no set dosing protocol for the blend, with amounts varying by desired outcome, body weight, and individual response.
- Frequency
- Research discussions describe subcutaneous or intramuscular injection, as well as oral capsule formulations.
- Timing
- Timing is not consistently defined across the available research references.
- Cycle length
- Cycle length is not consistently defined across the available research references.
- Notes
- These details are educational context only. Protocol values are examples and should not be treated as medical instructions.
Known Risks
- Individual responses vary; mild-to-moderate reactions reported
- Possible allergic reactions
Regulatory & Evidence Status
- Evidence level
- Limited blend-specific research; much of the data comes from studies of the individual components.
- FDA status
- Not approved as a drug.
- WADA status
- Component compounds are prohibited.
References
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
Frontiers in Pharmacology · 2021
DOI: 10.3389/fphar.2021.627533
Synthesis and characterization of the N‐terminal acetylated 17‐23 fragment of thymosin beta 4 identified in TB‐500, a product suspected to possess doping potential
Drug Testing and Analysis · 2012
DOI: 10.1002/dta.1402
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Journal of Applied Physiology · 2011
DOI: 10.1152/japplphysiol.00945.2010
Animal studies with thymosin β 4 , a multifunctional tissue repair and regeneration peptide
Annals of the New York Academy of Sciences · 2010
DOI: 10.1111/j.1749-6632.2010.05479.x
Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation
Journal of Molecular Medicine · 2017
DOI: 10.1007/s00109-016-1488-y
BPC 157 as Potential Treatment for COVID-19
Medical Hypotheses · 2022
DOI: 10.1016/j.mehy.2021.110736
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Current Neuropharmacology · 2016
DOI: 10.2174/1570159x13666160502153022
The pharmacological properties of the novel peptide BPC 157 (PL-10)
Inflammopharmacology · 1999
DOI: 10.1007/s10787-999-0022-z
The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants
Journal of Physiology-Paris · 2000
DOI: 10.1016/s0928-4257(00)00148-0
Stable gastric pentadecapeptide BPC 157 for colitis and multiple sclerosis: Healing of cysteamine‐colitis and colon‐colon‐ anastomosis
The FASEB Journal · 2013
DOI: 10.1096/fasebj.27.1_supplement.1093.18
Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth
Journal of Orthopaedic Research · 2003
DOI: 10.1016/s0736-0266(03)00110-4
BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection
Current Pharmaceutical Design · 2020
DOI: 10.2174/1381612826666200523180301
For research and educational purposes only. Not medical advice. Consult a qualified healthcare professional before using any peptide. All calculations should be independently verified.
